Scientists recently reported that the use of next-generation sequencing may help improve the treatment strategies for advanced cancer patients with progressing tumors. The study highlighted some challenges that could be holding clinical genomics back. What do you think is the biggest obstacle?
What is the main obstacle holding back clinical genomics?
Cost of sequencing
Sequencing’s inherent limitations
Reporting delays/information custody issues
Complexity of sharing and understanding data